Compare OMER & AMWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMER | AMWD |
|---|---|---|
| Founded | 1994 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 788.4M | 872.8M |
| IPO Year | 2008 | 1995 |
| Metric | OMER | AMWD |
|---|---|---|
| Price | $10.80 | $39.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $32.50 | ★ $63.50 |
| AVG Volume (30 Days) | ★ 703.2K | 227.3K |
| Earning Date | 03-12-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $29,868,000.00 | ★ $1,709,585,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.95 | $35.51 |
| 52 Week High | $17.65 | $72.16 |
| Indicator | OMER | AMWD |
|---|---|---|
| Relative Strength Index (RSI) | 39.68 | 31.76 |
| Support Level | $10.55 | N/A |
| Resistance Level | $11.93 | $58.01 |
| Average True Range (ATR) | 0.46 | 1.72 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 9.85 | 31.79 |
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.